Cernostics Announces Scientific Presentations at DDW and ISPOR Meetings Demonstrating Clinical Validation and Cost-Effectiveness of New TissueCypher® Barrett's Esophagus Assay

Test Predicts Development of Esophageal Cancer in Patients with Barrett’s Esophagus

Bethlehem, PA –  Cernostics, Inc. Read More

Cernostics Announces Scientific Presentations at DDW and ISPOR Meetings Demonstrating Clinical Validation and Cost-Effectiveness of New TissueCypher® Barrett's Esophagus Assay2022-02-24T17:34:54+00:00
Go to Top